Last time we looked Poly-ICLC isn't approved for anything yet. It that's the case, as great as it may be, it would only be available for patients if they're in a trial using it. If DCVax-L is approved, it might be a trial sponsored by Onclovir to gain approval of Poly-ICLC.
Does anyone know, is Poly-ICLC being considered for approval elsewhere. It's clearly of tremendous benefit when used with DCVax-L, it's a shame to have to wait for years while it goes through a new trial with DCVax-L before it's available to all.
Gary
Bullish
Market Data 
Markets 
AI
